GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, KIT, MMP2, MMP9, NR3C1, PPARA, RORC, SRC, TERT, TYR |
9.06974 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, KIT, MMP9, SRC, TERT |
8.97989 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, KIT, MMP2, NR3C1, PPARA, RORC, SRC, TYR |
8.97989 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, ALPL, APP, AR, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, FABP3, HSD17B2, IGF1R, MMP2, MMP9, NR3C1, PPARA, RORC, SRC, TYR |
8.70414 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, KIT, MET, PPARA |
8.31012 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
8.25397 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
8.14727 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DNMT1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, NR3C1, RORC, SRC, TERT |
7.62054 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, KDR, KIT, MET, MMP12, MMP9, SRC, TERT, TNKS, TNKS2, XDH |
7.62054 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, KDR, KIT, MET, MMP12, MMP9, SRC, TERT, TNKS, TNKS2, XDH |
7.61386 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, ALPL, AR, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, NR3C1, RORC, SRC, TYR |
7.51162 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, AKR1C3, ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, FABP3, FLT3, IGF1R, KIT, MMP2, NR3C1, PPARA, SRC |
7.33519 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP2, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
7.33348 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, FABP4, FLT3, FUT7, HSD17B2, KDR, KIT, MET, MMP2, MMP9, PGR, PIM1, PPARA, PTPRS, RORC, SRC, TERT, TNKS2, TYR |
7.08056 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AR, BCL2, CSNK2A1, CYP1B1, DNMT1, FABP3, FLT3, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PGR, PIM1, SRC, TERT, XDH |
6.97344 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, NR3C1, RORC, SRC |
6.7782 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FLT3, NR3C1, RORC, SRC, TYR |
6.61744 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, FABP3, FLT3, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
6.61744 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
6.42979 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, KDR, KIT, MET, PPARA, SRC, TERT, TNKS, TNKS2, XDH |
6.40483 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, AKR1C3, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, FABP3, FLT3, KIT, NR3C1, PPARA, SRC |
6.25968 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, KDR, KIT, MET, MMP12, MMP9, SRC, TERT, TNKS, TNKS2, XDH |
6.0559 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, PIM1, PPARA, TYR, XDH |
5.91256 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
5.84205 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, FABP4, KIT, MMP9, TERT |
5.77423 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2 |
5.69903 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, MMP12, MMP9, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
5.69903 |
[BP] GO:0015701 |
bicarbonate transport
|
CA12, CA14, CA2, CA4, CA7, CA9 |
5.64284 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, MMP12, MMP9, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
5.60904 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, FLT3, HSD17B2, KDR, KIT, MMP9, PGR, PIM1, PPARA, PTPRS, RORC, SRC, TYR |
5.55035 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, KDR, KIT, PPARA, PTPRS, SRC, TYR |
5.45461 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, PIM1, SRC |
5.43501 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DNMT1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, NR3C1, RORC, SRC, TERT |
5.38866 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, SRC, TERT |
5.1778 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
5.17203 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
5.14119 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, KIT, MET, PPARA |
5.13547 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
5.12692 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, FABP4, FLT3, KDR, KIT, MET, MMP12, MMP2, MMP9, SRC, TERT, TNKS, TNKS2, XDH |
4.96504 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
4.9578 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AR, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, FABP4, HSD17B2, IGF1R, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TNKS2, TYR |
4.9578 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AKR1C3, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, SRC, TERT, XDH |
4.94236 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, KIT, MET, MMP9, PIM1, SRC, TERT |
4.94236 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
4.87902 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AKR1C3, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, IGF1R, KDR, KIT, MET, MMP9, PIM1, SRC, TERT, XDH |
4.73399 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, NR3C1, PPARA, RORC, SRC, TERT, TYR |
4.69723 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.67322 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR3C1, PGR, PIM1, PPARA, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.63036 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA12, CA2, CA4, CA7, CA9 |
4.59097 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
4.56524 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
4.5541 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, ALPL, APP, AR, CYP1A1, CYP1B1, FLT3, NR3C1, RORC, SRC |
4.54869 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
4.51403 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.47718 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
4.41482 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CYP1B1, FLT3, KDR, KIT, MET, SRC, XDH |
4.39132 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, MMP9, SRC, XDH |
4.32667 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, AKR1C3, ALOX15, APP, AR, AURKB, BCL2, DNMT1, DYRK1A, FABP3, FLT3, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR3C1, PGR, PPARA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.32652 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DYRK1A, KIT, PGR, PPARA, RORC, SRC |
4.32022 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
4.30475 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AKR1C3, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.30055 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, AKR1C3, ALOX15, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DYRK1A, FABP3, FLT3, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR3C1, PGR, PPARA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.30055 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, BCL2, DNMT1, IGF1R, KDR, KIT, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
4.20995 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA |
4.20795 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, FABP4, FLT3, IGF1R, KDR, KIT, MET, MMP12, MMP2, MMP9, PPARA, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
4.18032 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AKR1C3, AR, BCL2, CSNK2A1, FLT3, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, TERT |
4.16556 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, APP, AR, AXL, CYP1B1, DNMT1, IGF1R, MMP2, MMP9, NR3C1, RORC, SRC |
4.13689 |
[BP] GO:0048545 |
response to steroid hormone
|
AKR1C3, ALPL, AR, BCL2, CA2, FLT3, NR3C1, SRC |
4.13462 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, TYR, XDH |
4.11619 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR3C1, PGR, PPARA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
4.08399 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.03426 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, TYR |
4.02399 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
4.0153 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AR, AURKB, BCL2, CYP1A1, FLT3, KIT, MET, PIM1, SRC, TYR |
3.97117 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, TNKS |
3.92112 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
3.90384 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
3.82437 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, KIT, MMP9, TERT |
3.80657 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.78613 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR3C1, PGR, PPARA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.78613 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.78112 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT, TNKS |
3.77279 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, IGF1R, KDR, KIT, MET, MMP12, MMP9, PPARA, SRC, TERT |
3.75452 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, CYP1B1, MMP9, SRC |
3.74603 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, BCL2, CYP1B1, MMP9, SRC |
3.74124 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, MMP12, MMP9, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
3.74124 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, NR3C1, PGR, PIM1, PPARA, RORC, SRC |
3.73064 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD17B1, HSD17B2 |
3.66578 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MMP9, PIM1, SRC, TERT |
3.63317 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AKR1C3, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, IGF1R, KDR, MMP9, PIM1, SRC, TERT, XDH |
3.61066 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, AKR1C3, CYP1A1, FABP3, FLT3, KIT, PPARA, RORC, SRC |
3.60974 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AKR1C3, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DYRK1A, FABP4, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PGR, PPARA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.59055 |
[BP] GO:0048608 |
reproductive structure development
|
AKR1C3, AR, AXL, BCL2, CYP19A1, HSD17B2, KIT, SRC |
3.58042 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
3.58042 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.57687 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.57687 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.57687 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.47595 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.4634 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.41989 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, PTPRS, SRC, TNKS, XDH |
3.36855 |
[BP] GO:0071383 |
None
|
AKR1C3, AR, FLT3, NR3C1, SRC |
3.30608 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.27992 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.27992 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AKR1C3, ALPL, APP, AR, AXL, BCL2, CBR1, CYP1A1, FABP4, FLT3, FUT7, KDR, KIT, MET, MMP2, MMP9, PGR, PTPRS, RORC, SRC, TERT |
3.22948 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
3.17291 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.15612 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, PTPRS, SRC, TNKS, XDH |
3.10373 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, AKR1C3, APP, AR, DNMT1, FLT3, IGF1R, KIT, MMP2, NR3C1, SRC |
3.08356 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, AKR1C3, DNMT1, FABP3, HSD17B2, KDR, MMP2, SRC |
3.08356 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, FABP4, MMP9 |
3.06582 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
3.02919 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, TNKS |
3.02919 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.00911 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, KIT, MMP2, PPARA, SRC, TERT, TYR |
2.97585 |
[BP] GO:0031960 |
response to corticosteroid
|
AKR1C3, ALPL, BCL2, FLT3, NR3C1, SRC |
2.97234 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.96049 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AKR1C3, ALPL, APP, AR, AXL, BCL2, CYP19A1, CYP1A1, HSD17B2, KIT, MMP2, MMP9, PGR, SRC |
2.91851 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AKR1C3, APP, AXL, BCL2, CYP1B1, MMP9, SRC |
2.91709 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.91125 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
2.91125 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, NR3C1, NR3C2, PGR, PPARA, RORC |
2.91125 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
2.89924 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
2.89924 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
2.89924 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
2.89924 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC, TNKS |
2.87292 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, BCL2, CA9, CYP1A1, CYP1B1, FABP3, KDR, NR3C1, SRC |
2.84723 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
2.84324 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AKR1C3, ALPL, AR, AXL, BCL2, CYP19A1, HSD17B2, KIT, PGR, SRC |
2.83994 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
2.83994 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, KDR, SRC, TNKS, TNKS2 |
2.82208 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.81488 |
[BP] GO:0032787 |
None
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA |
2.7984 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SRC, TERT |
2.79562 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, FABP4, MMP9 |
2.77923 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, KIT, MMP9, RORC |
2.77923 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, DNMT1, KDR, MET, MMP9, SRC, TNKS, TNKS2 |
2.76193 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
2.74719 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SRC, TERT |
2.72827 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
AKR1C3, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DYRK1A, FABP4, IGF1R, MET, MMP12, MMP9, NR3C1, PPARA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.72443 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, NR3C1, SRC |
2.71508 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, PPARA |
2.70377 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.69059 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, SRC |
2.69059 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.68069 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1 |
2.67632 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.65916 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.63938 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
2.63938 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, APP, CYP19A1, DYRK1A, FABP4, IGF1R, MET, MMP12, MMP2, PPARA, PTPRS, SRC, TERT, XDH |
2.6353 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, APP, AR, FLT3, KDR, KIT, SRC, XDH |
2.63066 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.62398 |
[BP] GO:0030098 |
lymphocyte differentiation
|
AXL, BCL2, FLT3, FUT7, KIT, RORC |
2.61448 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CSNK2A1, CYP1A1, CYP1A2, DYRK1A, FLT3, FUT7, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPRS, SRC, TNKS, TNKS2, TYR, XDH |
2.57216 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.56914 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, AR, BCL2, CYP19A1, DYRK1A, IGF1R, MET, MMP12, MMP9, PPARA, PTPRS, SRC, TERT, XDH |
2.56603 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.56179 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, AXL, CYP1B1, MMP9, SRC |
2.549 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, KDR, SRC |
2.54392 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SRC, TERT |
2.5427 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.53494 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.53494 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.53494 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, TERT, TNKS, TNKS2 |
2.49186 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.46654 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, KIT |
2.46654 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, KIT |
2.46654 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.45355 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
2.45355 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, SRC |
2.44715 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, SRC, TNKS |
2.44715 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, NR3C1, NR3C2, PGR, PPARA, RORC |
2.44715 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1 |
2.41886 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.41886 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, KDR, SRC |
2.41886 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, ALOX15, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, HSD17B2 |
2.41886 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.41504 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD17B1, HSD17B2 |
2.41276 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.41276 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, FABP3, FABP4, FLT3, MET, SRC, TERT |
2.41211 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, KIT, MET, SRC, XDH |
2.39879 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, AKR1C3, ALOX15, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.39738 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.39538 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, DNMT1, IGF1R, SRC, TNKS, TNKS2 |
2.38462 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PIM1, PPARA, TYR |
2.38045 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.38045 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.3786 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, APP, AR, BCL2, DNMT1, DYRK1A, FLT3, KDR, KIT, MMP9, SRC, XDH |
2.33166 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, APP, AR, FLT3, IGF1R, KDR, KIT, SRC, XDH |
2.32723 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.32723 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, AKR1C3, ALOX15, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.31533 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.30544 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.30544 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1 |
2.29698 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, AKR1C3, ALOX15, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.28995 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, FABP3, IGF1R, KDR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SRC, TERT, TNKS, TNKS2 |
2.26777 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APP, AR, AURKB, CSNK2A1, DNMT1, DYRK1A, FABP4, IGF1R, KDR, MMP12, MMP9, NR3C1, PGR, PPARA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.24568 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.24241 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.23702 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.21708 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.20146 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, SRC, TNKS, TNKS2 |
2.20146 |
[BP] GO:0022602 |
ovulation cycle process
|
BCL2, KIT, PGR, SRC |
2.15908 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, TERT |
2.15908 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DNMT1, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TYR |
2.15674 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.14032 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, IGF1R, KDR, MET, MMP12, NR3C1, PGR, PPARA, RORC, SRC, TERT, TNKS, TNKS2 |
2.13438 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CSNK2A1, DYRK1A, FLT3, FUT7, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPRS, SRC, TNKS, TNKS2 |
2.13402 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1 |
2.13148 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.13148 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
BCL2, CSNK2A1, DYRK1A, TNKS |
2.13148 |
[BP] GO:0032204 |
None
|
AURKB, SRC, TNKS, TNKS2 |
2.13148 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, NR3C1, PGR, SRC |
2.13148 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, AR, BCL2, FABP3, FLT3, KDR, KIT, MMP9, SRC, XDH |
2.13148 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, AR, BCL2, FABP3, FLT3, KDR, KIT, MMP9, SRC, XDH |
2.13148 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, BCL2, DYRK1A, IGF1R, MET, MMP12, MMP9, PTPRS, SRC, TERT, XDH |
2.12841 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, FLT3, FUT7, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TYR, XDH |
2.12672 |
[BP] GO:0071396 |
cellular response to lipid
|
AKR1C3, AR, AXL, FLT3, NR3C1, RORC, SRC |
2.12652 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AKR1C3, AXL, KIT, MET, SRC |
2.12451 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.12451 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.12451 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, AR, BCL2, DYRK1A, IGF1R, MET, MMP12, MMP9, PTPRS, SRC, TERT, XDH |
2.12451 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1 |
2.1065 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.1065 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC |
2.1065 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, NR3C1, SRC |
2.09229 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.09229 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, AR, BCL2, FLT3, KDR, KIT, MMP9, SRC, XDH |
2.08954 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, DNMT1, IGF1R, KDR, KIT, MET, MMP1, MMP9, PTPRS, SRC, TNKS, TNKS2 |
2.08904 |
[BP] GO:0043436 |
oxoacid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PIM1, PPARA, TYR |
2.08455 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, CA2, CA7 |
2.07779 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
AKR1C3, CYP1A2, MMP9 |
2.07418 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, APP, AR, BCL2, FABP4, FLT3, IGF1R, KDR, KIT, MMP9, PPARA, SRC, XDH |
2.05735 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, FABP4, FLT3, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.04716 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.03849 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, APP, AXL, BCL2, CA2, CYP19A1, MMP12, SRC, TERT |
2.03511 |
[BP] GO:0006082 |
organic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PIM1, PPARA, TYR |
2.02935 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
BCL2, CSNK2A1, DYRK1A, TNKS |
2.02935 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, AKR1C3, ALOX15, CYP19A1, TYR |
2.02656 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, DNMT1, IGF1R, MET, MMP12, NR3C1, PGR, PPARA, RORC, SRC, TERT, TNKS, TNKS2 |
2.01853 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, KIT, SRC |
2.01164 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.01164 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX15, ALOX5 |
2.01164 |
[BP] GO:0016115 |
None
|
AKR1B10, AKR1C3 |
2.01164 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, DYRK1A, SRC, TNKS |
2.00105 |
[BP] GO:0030177 |
positive regulation of Wnt signaling pathway
|
CSNK2A1, SRC, TERT, TNKS, TNKS2 |
2.00105 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALOX5, ALPL, APP, AR, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, FUT7, HSD17B2, IGF1R, KDR, KIT, MET, MMP2, NR3C2, PGR, PIM1, PTPRS, SRC, TERT, TNKS, TNKS2, TYR |
2.39879 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA4, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, FUT7, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
2.29698 |
[CC] GO:0043226 |
organelle
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA4, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, FUT7, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
2.11984 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALPL, APP, AR, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CSNK2A1, FLT3, IGF1R, KDR, KIT, MET, MMP2, PIM1, PTPRS, SRC, TERT |
1.85291 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP |
1.81276 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, APP, AR, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, TNKS, TYR, XDH |
14.0153 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
10.8006 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AURKB, AXL, BACE1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPRS, SRC, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
10.6398 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
8.22231 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA12, CA2, CA4, CA7, CA9, DNMT1, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PPARA, RORC, TNKS |
6.83283 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, APP, AR, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, KIT, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, TERT, TNKS, TNKS2, TYR, XDH |
5.98636 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, APP, AR, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, KIT, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, RORC, TERT, TNKS, TNKS2, TYR, XDH |
5.64284 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
5.14119 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, NR3C1, NR3C2, PGR, PPARA, RORC |
4.9842 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, TYR, XDH |
4.97739 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.91258 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
4.62443 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
4.4975 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.38705 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, CBR1, HSD17B1, HSD17B2, XDH |
4.3172 |
[MF] GO:0005496 |
steroid binding
|
AR, HSD17B1, NR3C1, NR3C2, PGR, RORC |
4.21281 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
4.0153 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.93147 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.84673 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.67385 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, CBR1, HSD17B1, HSD17B2 |
3.55761 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, PPARA, SRC |
3.50249 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
3.24786 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, FABP3, FABP4, HSD17B1, NR3C1, NR3C2, PGR, PPARA, RORC |
3.11772 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, NR3C1 |
3.04828 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.97234 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
2.89924 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, XDH |
2.89136 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.85751 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, PGR, PPARA, RORC |
2.74581 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, PGR, PPARA, RORC |
2.74581 |
[MF] GO:0016829 |
lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
2.65071 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
2.64808 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.53494 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, TERT |
2.40618 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.39516 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
2.38462 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, AXL, FLT3, IGF1R, KDR, KIT, MET, NR3C1, NR3C2, PGR, PPARA, RORC |
2.38462 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ADORA1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, SRC, TUBB3, XDH |
2.29773 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.27139 |
[MF] GO:0004033 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.24241 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, BCL2, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, MMP9, PGR, TERT, TYR, XDH |
2.22206 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1C3, HSD17B1, HSD17B2 |
2.20146 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, APP, AURKB, AXL, CSNK2A1, DYRK1A, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, PTPRS, SRC, TUBB3, XDH |
2.17208 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
AKR1C3, HSD17B1, HSD17B2 |
2.13148 |
[MF] GO:0051879 |
Hsp90 protein binding
|
CSNK2A1, KDR, NR3C1 |
2.03849 |
[MF] GO:0047035 |
testosterone dehydrogenase (NAD+) activity
|
AKR1C3, HSD17B2 |
2.01164 |